期刊
CARBOHYDRATE POLYMERS
卷 103, 期 -, 页码 319-324出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.carbpol.2013.12.044
关键词
Polysaccharide; miRNA; Antitumor; Hepatocarcinoma; Ganoderma lucidum; Immune
资金
- NSF of China [20875038, 31271918]
Medicinal mushroom polysaccharides such as Ganoderma lucidum polysaccharides (GLPs) have been commonly hypothesized to suppress tumor cells proliferation through immune effects. To verify this hypothesis through investigating comprehensive miRNA expression in polysaccharide treated cancer cells, an anticancer mycelia GLP was employed to disclose miRNA differential expression of human hepatocarcinoma cells (HepG2), by using a miRNA microarray assay based on Sanger miR-Base Release 16. The experiment and the analysis result indicates that among the 61 differential expressed miRNAs (p <= 0.01), 17 of them were regulated significantly. GLP can inhibit HepG2 cells directly through regulation of hepatocarcinoma genes. A newly found miR-3131 exhibited the strongest upregulation (92-folds, Log 2 = 6.53, p=0.000016). The miRNAs responded synergistically in both hepatocarcinoma and immune-related aspects. (C) 2014 Elsevier Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据